Kidney diseases, atherosclerosis, colon cancer, non-alcoholic fatty liver disease and neurological disorders are five global health problems that the first five research projects in the Open Discovery Innovation Network (ODIN) are now addressing. In the projects, Ken Howard, Jørgen Kjems, and Daniel Otzen are among AU researchers and the pharmaceutical industry who are working together in full openness to generate new knowledge and new tools that can be used to develop new drugs.

Associate Professor Ken Howard is collaborating with 11 European partners in a new consortium funded by the European Commission. Through the training of young researchers, the aim is to pave the way for developing regenerative medicine for osteoarthritis and intervertebral disc degeneration by means of non-viral gene therapy.

Associate Professor Victoria Birkedal has received a grant from the Nordisk Foundation with which she will be able to establish Aarhus single molecule fluorescence infrastructure (ASiMoF) for advanced studies of molecular structure, dynamics and function in nano- and bio-systems.

7 iNANO researchers have received between DKK 100,000 and 2,234,000 from the Carlsberg Foundation for specific instruments. The foundation has awarded a total of DKK 67 million for research infrastructure, which aims to strengthen existing research and enable new ideas. In total DKK 6.5 million has been awarded to iNANO researchers.